STOCK TITAN

Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Electromed, Inc. (AMEX: ELMD) will release its fiscal 2023 third quarter financial results on May 9, 2023, after market close. A conference call to discuss the results is set for the same day at 5:00 p.m. Eastern Time. Interested participants can join by calling (888) 999-5318 for domestic or (848) 280-6460 for international lines. The live webcast will be available on Electromed's Investor Relations website. For those unable to join live, a replay will be accessible via phone and online, using the provided links. Electromed specializes in airway clearance technologies, notably the SmartVest® Airway Clearance System, serving patients with compromised pulmonary function.

Positive
  • None.
Negative
  • None.

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 third quarter ended March 31, 2023, on Tuesday, May 9, 2023 after the close of the stock market, and host a conference call at the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing (888) 999-5318 (Domestic) or (848) 280-6460 (International).

The live conference call webcast will be accessible in the Investor Relations section of Electromed’s web site and directly via the following link: https://viavid.webcasts.com/starthere.jsp?ei=1611768&tp_key=c1df4a5c0f

For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing the replay pin number 0151926. Additionally, an online replay will be available in the Investor Relations section of Electromed’s web site at: http://investors.smartvest.com/.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Brad Nagel, Chief Financial Officer

(952) 758-9299

investorrelations@electromed.com

Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

mike.cavanaugh@westwicke.com

Source: Electromed, Inc.

FAQ

When will Electromed announce its third quarter 2023 financial results?

Electromed will announce its third quarter 2023 financial results on May 9, 2023, after market close.

What time is the Electromed conference call for third quarter results?

The conference call is scheduled for May 9, 2023, at 5:00 p.m. Eastern Time.

How can I participate in Electromed's conference call?

Participants can join by calling (888) 999-5318 for domestic or (848) 280-6460 for international access.

Where can I find the replay of Electromed's conference call?

A replay will be available by calling (844) 512-2921 for domestic or (412) 317-6671 for international. An online replay will also be available on Electromed's Investor Relations website.

What products does Electromed manufacture?

Electromed manufactures airway clearance products, including the SmartVest® Airway Clearance System.

Electromed, Inc.

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Stock Data

253.39M
6.69M
27.77%
36.07%
1.73%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
NEW PRAGUE